Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$92.08
-0.4%
$92.36
$73.10
$96.44
$3.01B0.84208,427 shs246,626 shs
Chemed Co. stock logo
CHE
Chemed
$561.65
+0.4%
$620.66
$492.84
$654.62
$8.50B0.4683,809 shs70,751 shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$67.78
-1.2%
$73.46
$60.01
$82.63
$8.71B0.87886,214 shs1.17 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$29.81
-0.3%
$31.64
$24.23
$35.74
$5.18B1.261.60 million shs2.08 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
-0.38%+0.32%-0.58%-2.74%+17.11%
Chemed Co. stock logo
CHE
Chemed
+0.42%+0.24%-11.39%-6.56%+2.05%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-1.20%-7.32%-7.71%-10.98%-15.29%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
-0.27%+0.68%-7.34%-5.49%-9.09%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amedisys, Inc. stock logo
AMED
Amedisys
2.7654 of 5 stars
1.12.00.05.02.61.71.3
Chemed Co. stock logo
CHE
Chemed
4.8296 of 5 stars
2.53.03.34.92.52.52.5
Henry Schein, Inc. stock logo
HSIC
Henry Schein
4.5007 of 5 stars
3.23.00.03.41.92.52.5
Option Care Health, Inc. stock logo
OPCH
Option Care Health
4.9821 of 5 stars
3.55.00.04.13.33.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amedisys, Inc. stock logo
AMED
Amedisys
2.13
Hold$97.505.89% Upside
Chemed Co. stock logo
CHE
Chemed
3.00
Buy$681.0021.25% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.36
Hold$81.0919.64% Upside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
3.00
Buy$38.1327.89% Upside

Current Analyst Ratings

Latest CHE, AMED, OPCH, and HSIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$101.00
4/24/2024
Option Care Health, Inc. stock logo
OPCH
Option Care Health
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$38.00
3/26/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
3/25/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$97.00 ➝ $100.00
3/6/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$82.00 ➝ $88.00
3/6/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$74.00 ➝ $81.00
3/4/2024
Chemed Co. stock logo
CHE
Chemed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$604.00 ➝ $712.00
3/4/2024
Option Care Health, Inc. stock logo
OPCH
Option Care Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$36.00 ➝ $38.00
2/29/2024
Chemed Co. stock logo
CHE
Chemed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$625.00 ➝ $650.00
2/28/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$79.00 ➝ $83.00
2/28/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$82.00 ➝ $90.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amedisys, Inc. stock logo
AMED
Amedisys
$2.24B1.35$6.09 per share15.12$34.97 per share2.63
Chemed Co. stock logo
CHE
Chemed
$2.26B3.76$24.66 per share22.78$78.17 per share7.18
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.34B0.71$6.60 per share10.27$33.01 per share2.05
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$4.30B1.20$1.88 per share15.86$8.22 per share3.63

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amedisys, Inc. stock logo
AMED
Amedisys
-$9.75M-$0.64N/A18.493.44-0.91%12.85%6.95%7/24/2024 (Estimated)
Chemed Co. stock logo
CHE
Chemed
$272.51M$18.5830.2323.422.2912.36%30.52%20.13%7/24/2024 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$416M$3.1521.5212.171.703.37%14.03%6.22%5/7/2024 (Confirmed)
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$267.09M$1.5219.6121.601.456.15%18.92%8.37%7/25/2024 (Estimated)

Latest CHE, AMED, OPCH, and HSIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$0.99N/A-$0.99N/AN/AN/A  
4/24/2024Q1 2024
Amedisys, Inc. stock logo
AMED
Amedisys
$1.02$1.03+$0.01$1.62$565.38 million$571.41 million  
4/24/2024Q1 2024
Chemed Co. stock logo
CHE
Chemed
$5.09$4.68-$0.41$5.12$587.18 million$589.23 million    
4/23/2024Q1 2024
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.22$0.26+$0.04$0.26$1.10 billion$1.15 billion    
2/27/2024Q4 2023
Chemed Co. stock logo
CHE
Chemed
$6.25$6.60+$0.35$7.30$586.64 million$585.90 million    
2/27/202412/31/2023
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$0.70$0.66-$0.04$1.19$3.00 billion$3.02 billion      
2/22/2024Q4 2023
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.29$0.32+$0.03$0.32$1.09 billion$1.12 billion    
2/21/2024Q4 2023
Amedisys, Inc. stock logo
AMED
Amedisys
$1.04$0.94-$0.10$1.29$566.85 million$570.79 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
Chemed Co. stock logo
CHE
Chemed
$1.600.28%+5.73%8.61%15 Years
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A

Latest CHE, AMED, OPCH, and HSIC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Chemed Co. stock logo
CHE
Chemed
quarterly$0.400.27%2/23/20242/26/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amedisys, Inc. stock logo
AMED
Amedisys
0.31
1.09
1.09
Chemed Co. stock logo
CHE
Chemed
N/A
1.91
1.88
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.45
1.67
1.00
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.74
1.77
1.39

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
Chemed Co. stock logo
CHE
Chemed
95.85%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%

Insider Ownership

CompanyInsider Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
1.80%
Chemed Co. stock logo
CHE
Chemed
3.32%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.14%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.64%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
19,00032.68 million32.09 millionOptionable
Chemed Co. stock logo
CHE
Chemed
15,08715.14 million14.64 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000128.48 million127.02 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
7,802173.82 million172.70 millionOptionable

CHE, AMED, OPCH, and HSIC Headlines

SourceHeadline
Cannell & Co. Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)Cannell & Co. Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)
marketbeat.com - May 2 at 8:40 AM
Fidelis Care Grant to Aid OCO OPTIONS ProgramFidelis Care Grant to Aid OCO OPTIONS Program
oswegocountytoday.com - April 29 at 10:53 PM
Option Care Health to Participate in the BofA Securities Health Care ConferenceOption Care Health to Participate in the BofA Securities Health Care Conference
globenewswire.com - April 29 at 4:05 PM
Option Care details impact of cyberattackOption Care details impact of cyberattack
hmenews.com - April 28 at 10:42 AM
Option Care Health, Inc. (NASDAQ:OPCH) Expected to Post FY2024 Earnings of $1.15 Per ShareOption Care Health, Inc. (NASDAQ:OPCH) Expected to Post FY2024 Earnings of $1.15 Per Share
americanbankingnews.com - April 27 at 3:30 AM
William Blair Analysts Decrease Earnings Estimates for Option Care Health, Inc. (NASDAQ:OPCH)William Blair Analysts Decrease Earnings Estimates for Option Care Health, Inc. (NASDAQ:OPCH)
americanbankingnews.com - April 27 at 2:50 AM
Option Care (OPCH) Upgraded to Buy: Heres What You Should KnowOption Care (OPCH) Upgraded to Buy: Here's What You Should Know
zacks.com - April 26 at 1:00 PM
Results: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesResults: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
finance.yahoo.com - April 26 at 11:16 AM
Are Investors Undervaluing Option Care Health (OPCH) Right Now?Are Investors Undervaluing Option Care Health (OPCH) Right Now?
zacks.com - April 26 at 10:45 AM
FY2024 EPS Estimates for Option Care Health, Inc. Lifted by Analyst (NASDAQ:OPCH)FY2024 EPS Estimates for Option Care Health, Inc. Lifted by Analyst (NASDAQ:OPCH)
marketbeat.com - April 26 at 9:45 AM
Jennison Associates LLC Sells 136,848 Shares of Option Care Health, Inc. (NASDAQ:OPCH)Jennison Associates LLC Sells 136,848 Shares of Option Care Health, Inc. (NASDAQ:OPCH)
marketbeat.com - April 26 at 7:16 AM
Barrington Research Reiterates "Outperform" Rating for Option Care Health (NASDAQ:OPCH)Barrington Research Reiterates "Outperform" Rating for Option Care Health (NASDAQ:OPCH)
americanbankingnews.com - April 26 at 5:40 AM
Barrington Research Comments on Option Care Health, Inc.s Q1 2025 Earnings (NASDAQ:OPCH)Barrington Research Comments on Option Care Health, Inc.'s Q1 2025 Earnings (NASDAQ:OPCH)
americanbankingnews.com - April 26 at 4:20 AM
Option Care Health, Inc. (NASDAQ:OPCH) Expected to Post FY2024 Earnings of $1.19 Per ShareOption Care Health, Inc. (NASDAQ:OPCH) Expected to Post FY2024 Earnings of $1.19 Per Share
americanbankingnews.com - April 26 at 2:50 AM
Option Care Health, Inc. (NASDAQ:OPCH) Q1 2024 Earnings Call TranscriptOption Care Health, Inc. (NASDAQ:OPCH) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 25 at 2:07 PM
Option Care Health, Inc. (OPCH) Q1 2024 Earnings Call TranscriptOption Care Health, Inc. (OPCH) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 25 at 9:06 AM
Option Care Health, Inc. (NASDAQ:OPCH) to Post Q1 2025 Earnings of $0.30 Per Share, Barrington Research ForecastsOption Care Health, Inc. (NASDAQ:OPCH) to Post Q1 2025 Earnings of $0.30 Per Share, Barrington Research Forecasts
marketbeat.com - April 25 at 8:31 AM
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
markets.businessinsider.com - April 24 at 12:57 PM
Option Care Healths (OPCH) Outperform Rating Reaffirmed at Barrington ResearchOption Care Health's (OPCH) Outperform Rating Reaffirmed at Barrington Research
marketbeat.com - April 24 at 12:36 PM
Option Care Health (NASDAQ:OPCH) Issues Quarterly  Earnings ResultsOption Care Health (NASDAQ:OPCH) Issues Quarterly Earnings Results
marketbeat.com - April 24 at 9:45 AM
Option Care Health Inc (OPCH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...Option Care Health Inc (OPCH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
finance.yahoo.com - April 24 at 7:57 AM
Q1 2024 Option Care Health Inc Earnings CallQ1 2024 Option Care Health Inc Earnings Call
finance.yahoo.com - April 24 at 7:57 AM
Option Care Health (NASDAQ:OPCH) Sees Unusually-High Trading VolumeOption Care Health (NASDAQ:OPCH) Sees Unusually-High Trading Volume
marketbeat.com - April 23 at 3:44 PM
OPCH Stock Earnings: Option Care Health Beats EPS, Beats Revenue for Q1 2024OPCH Stock Earnings: Option Care Health Beats EPS, Beats Revenue for Q1 2024
investorplace.com - April 23 at 1:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Amedisys logo

Amedisys

NASDAQ:AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Chemed logo

Chemed

NYSE:CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Henry Schein logo

Henry Schein

NASDAQ:HSIC
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Option Care Health logo

Option Care Health

NASDAQ:OPCH
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.